Literature DB >> 33777145

Menstrual Pattern and Characteristics of One-Rod and Two-Rod Levonorgestrel Implant Users.

Eka Rusdianto Gunardi1, Sulaeman Andrianto Susilo1.   

Abstract

INTRODUCTION: The maternal mortality ratio (MMR) in Indonesia reaches 359 per 100,000 live births. The long-acting reversible contraceptive (LARC) method is an effective contraceptive choice for reducing MMR. The contraceptive implant is one of the LARCs that has low usage due to lack of education about the side effects. This study aims to compare the menstrual pattern and characteristics between one-rod and two-rod levonorgestrel implant users.
METHODS: A prospective cohort study was performed in patients at Cipto Mangunkusumo Hospital (RSCM) from March 2016 to May 2018. Subject recruitment was done by consecutive sampling. This study was conducted from March 2016 until May 2019. Statistical analysis was performed on the data using the chi-square test to determine the relationship between menstrual pattern and characteristics, and the use of one-rod or two-rod levonorgestrel implants.
RESULTS: A total of 140 subjects participated in the study, comprising 70 (50%) one-rod users and 70 (50%) two-rod users. In the first month, 32.9% one-rod users experienced amenorrhea, 22.9% experienced shortened menstrual period, 30% experienced normal menstrual period, and 14,2 % experienced lengthened menstrual period. In comparison, in the first month, 41.4% two-rod users experienced amenorrhea, 15.7% experienced shortened menstrual period, 32.9% experienced normal menstrual period, and 10% experienced lengthened menstrual period. There was no significant difference in menstrual patterns and characteristics between one-rod and two-rod levonorgestrel implant users.
CONCLUSION: There was no significant difference in menstrual patterns and characteristics between one-rod and two-rod levonorgestrel implant users. Implications. Menstrual patterns and characteristics from levonorgestrel implants user can help clinicians to reduce discontinuation rate from the acceptors. Further research should be conducted to know other side effects aside from menstrual bleeding patterns.
Copyright © 2021 Eka Rusdianto Gunardi and Sulaeman Andrianto Susilo.

Entities:  

Year:  2021        PMID: 33777145      PMCID: PMC7972863          DOI: 10.1155/2021/2904542

Source DB:  PubMed          Journal:  Obstet Gynecol Int        ISSN: 1687-9597


  31 in total

1.  Global patterns of mortality in young people: a systematic analysis of population health data.

Authors:  George C Patton; Carolyn Coffey; Susan M Sawyer; Russell M Viner; Dagmar M Haller; Krishna Bose; Theo Vos; Jane Ferguson; Colin D Mathers
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

2.  The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.

Authors:  Malcolm G Munro; Hilary O D Critchley; Ian S Fraser
Journal:  Int J Gynaecol Obstet       Date:  2018-10-10       Impact factor: 3.561

3.  The pharmacodynamics and efficacy of Implanon. An overview of the data.

Authors:  H B Croxatto; L Mäkäräinen
Journal:  Contraception       Date:  1998-12       Impact factor: 3.375

4.  Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group.

Authors:  J Bitzer; S Tschudin; J Alder
Journal:  Eur J Contracept Reprod Health Care       Date:  2004-12       Impact factor: 1.848

5.  Insertion and removal of Norplant contraceptive implants by physicians and nonphysicians in an Indonesian clinic.

Authors:  B Affandi; J Prihartono; F Lubis; H Sutedi; R S Samil
Journal:  Stud Fam Plann       Date:  1987 Sep-Oct

Review 6.  Contraceptive implants and lactation.

Authors:  Soledad Díaz
Journal:  Contraception       Date:  2002-01       Impact factor: 3.375

7.  Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.

Authors:  Jody E Steinauer; Ushma D Upadhyay; Abby Sokoloff; Cynthia C Harper; Justin T Diedrich; Eleanor A Drey
Journal:  Contraception       Date:  2015-06-17       Impact factor: 3.375

8.  Source of care and variation in long-acting reversible contraception use.

Authors:  Lauren Groskaufmanis; Saba W Masho
Journal:  Fertil Steril       Date:  2015-11-11       Impact factor: 7.329

9.  Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.

Authors:  Arijit Biswas; Osborne A C Viegas; Asim C Roy
Journal:  Contraception       Date:  2003-09       Impact factor: 3.375

Review 10.  Global causes of maternal death: a WHO systematic analysis.

Authors:  Lale Say; Doris Chou; Alison Gemmill; Özge Tunçalp; Ann-Beth Moller; Jane Daniels; A Metin Gülmezoglu; Marleen Temmerman; Leontine Alkema
Journal:  Lancet Glob Health       Date:  2014-05-05       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.